Last reviewed · How we verify
Zoledronic acid, pravastatin
At a glance
| Generic name | Zoledronic acid, pravastatin |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria (PHASE2)
- Pravastatin Reduces Acute Phase Response of Zoledronic Acid (PHASE4)
- A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria (PHASE2)
- Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |